Marketwatch J&J to pay $158 million to settle Risperdal case:
"Johnson & Johnson's Janssen Pharmaceuticals unit said Thursday it has reached a settlement with the State of Texas under which it will pay $158 million "in full resolution of all claims" in litigation over its antipsychotic drug Risperdal. The deal will cover claims brought by the state in 2004 for Medicaid overpayment from 1994 to 2008 "and will circumvent potentially lengthy and costly appellate activities," the company said."
With expert witnesses such as Bruce Perry, Joseph Glenmullen and whistle blower Allen Jones testifying, no wonder J&J Janssen wanted to settle, but the question remains, as to why they got off so cheap!!
Subscribe to:
Post Comments (Atom)








0 comments:
Post a Comment